THE COMPANY OF BIOLOGISTS

Registered charity 277992 · accounts filings on the Charity Commission register · also known as THE COMPANY OF BIOLOGISTS LIMITED

To promote research and study across all branches of biology through the publication of journals: Development, Journal of Cell Science, Journal of Experimental Biology, Disease Models & Mechanisms and Biology Open. To provide free access to journal content in the developing world and to fund workshops, grants and travelling fellowships to support the scientific community.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Arts/culture/heritage/science · Environment/conservation/heritage · Grant history (this charity is a funder) · website · Get email alerts

Latest income
£8.4m
Latest spending
£9.8m
Registered
1979
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity achieved a surplus of £6,034,698 for the year, driven primarily by investment gains, while total unrestricted funds stood at £84.8 million. The trustees consider the current level of reserves sufficient to mitigate financial risks and maintain ongoing operations, although they acknowledge that income levels are plateauing and actions may be needed to prevent reserves from being depleted too rapidly. The charity remains in a healthy financial position with adequate resources to continue in operational existence.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: approximately £25m (held: £31.8m)
“The Finance and Operational Performance Audit Committee and Board of Trustees have reviewed the level of the reserves and believe that approximately £25m is required to mitigate financial risks associated with operational and capital expenditure identified in the risk register whilst maintaining ongoing operations and charitable giving. Consequently, the current level of reserves is considered sufficient.” — page 18
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: The Company provided support to the British Society for Developmental Biology (BSDB) for £107,500 (2024: £107,500); The British Society for Cell Biology (BSCB) for £107,500 (2024: £107,500); The Society of Experimental Biology (SEB) for £37,500 (2024: £37,500); University of Edinburgh for £11,950 (2024: £7,000); Cambridge University for £12,363 (2024: £21,324); University of Oxford for £4,000 (2024: £10,500); The Institute of Cancer Research for £0 (2024: £2,500); University of Manchester £1,500 (2024: £3,500); Babraham Institute £0 (2024: £3,800); Society for Integrative & Comparative Biology £3,000 (2024: £23); University of Liverpool £27,500 (2024: £0); University of Exeter £2,000 (2024: £0); EMBO £70,000 (2024: £70,000), Biochemical Society £0 (2024: £3,123); and Genticis Society of America £0 (2024:£3,940). Additionally, the Company made the following payments on a commercial basis to EMBO £1,152 (2024: £0); University of Cambridge £3,788 (2024: £0); SEB £2,689 (2024: £0); and the Society for Developmental Biology £3,143 (£0).
“The Company provided support to the British Society for Developmental Biology (BSDB) for £107,500 (2024: £107,500); The British Society for Cell Biology (BSCB) for £107,500 (2024: £107,500); The Society of Experimental Biology (SEB) for £37,500 (2024: £37,500); University of Edinburgh for £11,950 (2024: £7,000); Cambridge University for £12,363 (2024: £21,324); University of Oxford for £4,000 (2024: £10,500); The Institute of Cancer Research for £0 (2024: £2,500); University of Manchester £1,500 (2024: £3,500); Babraham Institute £0 (2024: £3,800); Society for Integrative & Comparative Biology £3,000 (2024: £23); University of Liverpool £27,500 (2024: £0); University of Exeter £2,000 (2024: £0); EMBO £70,000 (2024: £70,000), Biochemical Society £0 (2024: £3,123); and Genticis Society of America £0 (2024:£3,940). Additionally, the Company made the following payments on a commercial basis to EMBO £1,152 (2024: £0); University of Cambridge £3,788 (2024: £0); SEB £2,689 (2024: £0); and the Society for Developmental Biology £3,143 (£0). Of the grant commitments made to related organisations during the year £252,500 (2024 – £325,500) was outstanding and included within creditors at the year end.” — page 42
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Price Bailey LLP. Discloses 4 of 6 completeness components.

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Structured financials (annual return, FY ending 31/12/2025)

Total income
£8.4m
Total spending
£9.8m
Cost of raising funds
£680k
Reserves (reported)
£31.8m
Employees
68

Reported reserves equal ~39.1 months of spending — in the top quarter for charities its size (median 4.8 months; benchmarks).

Per its annual return, largest income source: Charitable activities (83% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 8.1% of total income — above the median for charities its size (5.2%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Argentina · Armenia · Aruba · Australia · Austria · Belgium · Canada · Chile · China · Costa Rica · Czech Republic · Denmark

Income and spending

Financial year endIncomeSpending
31/12/2025£8.4m£9.8m
31/12/2024£7.7m£9.2m
31/12/2023£7.8m£8.9m
31/12/2022£7.6m£6.9m
31/12/2021£7.6m£5.8m

Common questions

Is THE COMPANY OF BIOLOGISTS financially healthy?

Per its FY2025 accounts: The accounts state that the charity achieved a surplus of £6,034,698 for the year, driven primarily by investment gains, while total unrestricted funds stood at £84.8 million. The trustees consider the current level of reserves sufficient to mitigate financial risks and maintain ongoing operations, although they acknowledge that income levels are plateauing and actions may be needed to prevent reserves from being depleted too rapidly. The charity remains in a healthy financial position with adequate resources to continue in operational existence. Its FY2025 accounts were audited by Price Bailey LLP.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
THE BIOCHEMICAL SOCIETY1£18k
THE HORNERS CHARITY FUND1£6k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE ANNALS OF BOTANY COMPANY.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE COMPANY OF BIOLOGISTS£8.4m——above—no doubt
THE ANNALS OF BOTANY COMPANY FY2024£578k—0below—no doubt
THE PHYSIOLOGICAL SOCIETY FY2024£4.8m——above—no doubt
THE SOCIETY FOR EXPERIMENTAL BIOLOGY FY2024£2.9m——below—no doubt
BRITISH SOCIETY FOR CELL BIOLOGY FY2024£126k—0unclear—no doubt
THE ROYAL SOCIETY OF BIOLOGY FY2025£3.2m——above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.